Furthermore, high levels of CD47 were associated with advanced tumor staging or poorer prognosis in ACC, HNSC, KICH, KIRC, LGG, LICH, LUSC, OV, PAAD, RCC, THCA, UCEC, and UVM. Here, CD47 is linked to neoplasm.